May 16, 2016
Afferent Pharmaceuticals
Afferent Pharmaceuticals Presents Updated Positive Results with AF-219 from Phase 2B Chronic Cough Study at the 2016 American Thoracic Society (ATS) International Conference
May 16, 2016
Editas Medicine
Editas Medicine Announces First Quarter 2016 Results and Update
May 16, 2016
Editas Medicine
Editas Medicine Announces Agreement with Cystic Fibrosis Foundation Therapeutics to Advance New CRISPR/Cas9 Medicines
May 16, 2016
MyoKardia
MyoKardia to Present at 2016 UBS Global Healthcare Conference
May 12, 2016
MyoKardia
MyoKardia Reports First Quarter 2016 Financial Results and Operational Progress